Tested eye drops for safety in cataract patients with low cornea cells
Part of Eyes & vision clinical trials.
This Phase 1 study tests how safe and tolerable an investigational treatment (EO2002) is in adults having cataract surgery. It also looks at whether the treatment can be given without causing harmful effects in people with reduced cornea cell counts.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your cataract is progressing to the point you need standard cataract surgery with an artificial lens
- Your cornea has a lower-than-normal number of endothelial cells (needed for cornea clarity)
- You do not have other cornea problems besides the cataract-related issue
- No history of significant eye inflammation (like uveitis) or corneal membrane detachment
- You have not had certain recent or specific eye surgeries (within the last 3 months) and you are not pregnant or nursing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational cell therapy called EO2002 for people with corneal edema (swelling of the clear front part of the eye) caused by endothelial dysfunction, which can happen with Fuchs dystrophy or after cataract surgery. The treatment aims to restore the inner layer of the cornea to reduce swelling and improve vision.
This trial tests whether stem cell fortified eye drops can improve tear film stability, tear volume, and dry eye symptoms. If you have dry eye disease and haven't had eye surgery or certain other eye conditions, you may be able to join.
This Phase 1 study tests whether EO2002 eye drops are safe and well tolerated in people with painful corneal swelling caused by the cornea’s inner lining not working well. It focuses on safety first, but your eye symptoms and vision may be monitored to see how you respond.
This trial tests an eye drop called CA201A to see if it can prevent loss of cells in the clear front layer of the eye (the cornea) after cataract surgery. The drop contains ascorbic acid, a form of vitamin C, and is given before and after the procedure to help protect the eyesight.
This study tests an investigational eye drop called OT202 to see if it helps people with moderate to severe dry eye. If you join, you'll receive either the study drug or a placebo (no active ingredient) and have your symptoms and eye health monitored for several months.
This trial tests whether a new eye drop called BT01001 is safe for healthy adults. You may join if you have good overall and eye health, and do not use contact lenses or have chronic eye problems.
Hear when a new Cataract trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.